Use of a Combined Gene Expression Profile in Implementing a Drug Sensitivity Predictive Model for Breast Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Chemotherapy targets all rapidly growing cells, not only cancer cells, and thus is often associated with unpleasant side effects. Therefore, examination of the chemosensitivity based on genotypes is needed in order to reduce the side effects. Materials and Methods Various computational approaches have been proposed for predicting chemosensitivity based on gene expression profiles. A linear regression model can be used to predict the response of cancer cells to chemotherapeutic drugs, based on genomic features of the cells, and appropriate sample size for this method depends on the number of predictors. We used principal component analysis and identified a combined gene expression profile to reduce the number of predictors Results The coefficients of determinanation (R2) of prediction models with combined gene expression and several independent gene expressions were similar. Corresponding F values, which represent model significances were improved by use of a combined gene expression profile, indicating that the use of a combined gene expression profile is helpful in predicting drug sensitivity. Even better, a prediction model can be used even with small samples because of the reduced number of predictors. Conclusion Combined gene expression analysis is expected to contribute to more personalized management of breast cancer cases by enabling more effective targeting of existing therapies. This procedure for identifying a cell-type-specific gene expression profile can be extended to other chemotherapeutic treatments and many other heterogeneous cancer types.
Abstract
Purpose Chemotherapy targets all rapidly growing cells, not only cancer cells, and thus is often associated with unpleasant side effects. Therefore, examination of the chemosensitivity based on genotypes is needed in order to reduce the side effects. Materials and Methods Various computational approaches have been proposed for predicting chemosensitivity based on gene expression profiles. A linear regression model can be used to predict the response of cancer cells to chemotherapeutic drugs, based on genomic features of the cells, and appropriate sample size for this method depends on the number of predictors. We used principal component analysis and identified a combined gene expression profile to reduce the number of predictors Results The coefficients of determinanation (R2) of prediction models with combined gene expression and several independent gene expressions were similar. Corresponding F values, which represent model significances were improved by use of a combined gene expression profile, indicating that the use of a combined gene expression profile is helpful in predicting drug sensitivity. Even better, a prediction model can be used even with small samples because of the reduced number of predictors. Conclusion Combined gene expression analysis is expected to contribute to more personalized management of breast cancer cases by enabling more effective targeting of existing therapies. This procedure for identifying a cell-type-specific gene expression profile can be extended to other chemotherapeutic treatments and many other heterogeneous cancer types.
참고문헌 (22)
- Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
- DeSantis C, "Breast cancer statistics, 2013", CA Cancer J Clin, 64, pp.52~62 (2014)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)
- Oh HS, "Targeted therapy for breast cancer", Hanyang Med Rev, 32, pp.112~117 (2012)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2016", Cancer Research and Treatment, 48(2), pp.451~457 (2016), 대한암학회
- "BreastCancerTrials.org" (2016)[URL]
- Garnett MJ, "Systematic identification of genomic markers of drug sensitivity in cancer cells", Nature, 483, pp.570~575 (2012)
- Scherf U, "A gene expression database for the molecular pharmacology of cancer", Nat Genet, 24, pp.236~244 (2000)
- Kao J, "Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery", PLoS One, 4, pp.e6146~ (2009)
- Menden MP, "Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties", PLoS One, 8, pp.e61318~ (2013)
- Ferriss JS, "Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma:predicting platinum resistance", PLoS One, 7, pp.e30550~ (2012)
- Lee JK, "A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery", Proc Natl Acad Sci U S A, 104, pp.13086~13091 (2007)
- De Abreu FB, "Person-alized therapy for breast cancer", Clin Genet, 86, pp.62~67 (2014)
- Ring BZ, "Gene expression patterns within cell lines are predictive of chemosensitivity", BMC Genomics, 9, pp.74~ (2008)
- Wu D, "Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity", Br J Cancer, 109, pp.1599~1608 (2013)
- Knofczynski GT, "Sample sizes when using multiple linear regression for prediction", Educ Psychol Meas, 68, pp.431~442 (2008)
- Ku JM, "Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-kappaB signaling in doxorubicinresistant human breast carcinoma(MCF7", ADR)cells, 2015, pp.409, 33~43
- Felding-Habermann B, "PD03-07:Breast cancer heterogeneity and treatment resistance: clues from metaplastic tumors", Thirty-Fourth Annual CTRCAACR San Antonio Breast Cancer Symposium (2011)
- K. Fukunaga, "Introduction to Statistical Pattern Recognition" (1990), Academic Press
- "The R Project for Statistical Computing" (2016)[URL]
- Cohen J, "Statistical power analysis for the behavioral sciences" (1988), Lawrence Erlbaum Associates
- Heiser LM, "Subtype and pathway specific responses to anticancer compounds in breast cancer", Proc Natl Acad Sci U S A, 109, pp.2724~2729 (2012)